Osteoporosis natural history: Difference between revisions
| Line 15: | Line 15: | ||
* [[Kyphosis]] | * [[Kyphosis]] | ||
* [[Restrictive lung disease]] | * [[Restrictive lung disease]] | ||
* | * Drug side-effects: | ||
** [[Bisphosphonates]] - [[Esophagitis]], [[Osteonecrosis]] of the jaw, bone pain, muscle pain etc., | ** [[Bisphosphonates]] - [[Esophagitis]], [[Osteonecrosis]] of the jaw, bone pain, muscle pain etc., | ||
** [[Raloxifene]] - [[thromboembolism]], [[ | ** [[Raloxifene]] - [[thromboembolism]], aggravates [[hot flashes]], [[nausea]], [[weight gain]], [[depression]], [[insomnia]], leg cramps, rash | ||
** [[Teriparitide]] - [[orthostatic hypotension]], asthenia, nausea, leg cramps, [[hypercalcemia]] (if taken along with corticosteroids, thiazide diuretics, and calcium supplementation), must not be given to patients with [[Paget's disease]] or a history of [[osteosarcoma]] or [[chondrosarcoma]] | ** [[Teriparitide]] - [[orthostatic hypotension]], asthenia, nausea, leg cramps, [[hypercalcemia]] (if taken along with corticosteroids, thiazide diuretics, and calcium supplementation), must not be given to patients with [[Paget's disease]] or a history of [[osteosarcoma]] or [[chondrosarcoma]] | ||
** [[ | ** Nasal [[calcitonin-salmon ]] - [[bronchospasm]], [[rhinitis]], [[epistaxis]], arthralgias | ||
==Prognosis== | ==Prognosis== | ||
Revision as of 13:55, 20 July 2012
|
Osteoporosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Medical Therapy |
|
Case Studies |
|
Osteoporosis natural history On the Web |
|
American Roentgen Ray Society Images of Osteoporosis natural history |
|
Risk calculators and risk factors for Osteoporosis natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Disease can be complicated by the development of fractures. The prognosis of disease is good. Mortality from the disease depends on the type of fracture. The major type of fractures contributing to mortality in these patients are Vertebral fractures and Hip fractures.
Natural History
The symptoms of the disease typically develop in the sixth decade of life. The risk increases with age proportionately. DXA bone densitometry is recommended every 2–3 years. Outcome is usually good with appropriate usage of medications and with calcium and / or vitamin D supplementation.
Complications
Disease can be complicated by the development of:
- Fractures
- DVT - from prolonged immobility
- Kyphosis
- Restrictive lung disease
- Drug side-effects:
- Bisphosphonates - Esophagitis, Osteonecrosis of the jaw, bone pain, muscle pain etc.,
- Raloxifene - thromboembolism, aggravates hot flashes, nausea, weight gain, depression, insomnia, leg cramps, rash
- Teriparitide - orthostatic hypotension, asthenia, nausea, leg cramps, hypercalcemia (if taken along with corticosteroids, thiazide diuretics, and calcium supplementation), must not be given to patients with Paget's disease or a history of osteosarcoma or chondrosarcoma
- Nasal calcitonin-salmon - bronchospasm, rhinitis, epistaxis, arthralgias
Prognosis
The prognosis of the disease is good if the decrease in bone mass density is identified early and appropriate anti-osteoporotic medications are started. Disease is associated with a 1 year 5 year 10 year mortality of %. The presence of is associated with a poorer prognosis among patients with disease.